Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study

1. Yap, T.A.
2. Nakagawa, K.
3. Fujimoto, N.
4. Kuribayashi, K.
5. Guren, T.K.
6. Calabrò, L.
7. Shapira-Frommer, R.
8. Gao, B.
9. Kao, S.
10. Matos, I.
11. Planchard, D.
12. Chatterjee, A.
13. Jin, F.
14. Norwood, K.
15. Kindler, H.L.